Philip B. Donenberg serves as Executive at BIOSANTE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Philip B. Donenberg has executed 12 insider transactions totaling $16.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 8, 2011 involved purchasing 1,000 shares valued at $2.2K.
Philip B. Donenberg currently holds 44,322 shares of BIOSANTE PHARMACEUTICALS INC (BPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip B. Donenberg has been a net buyer of BPA stock. They have purchased $16.9K and sold $0 worth of shares.
Philip B. Donenberg's most recent insider trade was on Aug 8, 2011, when they purchased 1,000 shares at $2.23 per share.
Get notified when new Form 4 filings are submitted
| $2.19 |
| Discretionary |
| Jan 21, 2011 | BPAX | $1.9K | Purchase | 1,000 | $1.88 | Discretionary |
| Jan 19, 2011 | BPAX | $1.9K | Purchase | 1,000 | $1.88 | Discretionary |
| Dec 31, 2008 | BPAX | $3.0K | Purchase | 3,000 | $1.00 | Discretionary |
| Jul 29, 2008 | BPAX | $1.1K | Exercise | 500 | $2.15 | Discretionary |
| Dec 14, 2007 | BPAX | $1.9K | Purchase | 500 | $3.73 | Discretionary |
| Dec 14, 2007 | BPAX | $1.9K | Purchase | 500 | $3.78 | Discretionary |
| Jul 20, 2006 | BPA | $194 | Purchase | 100 | $1.94 | Discretionary |
| Jul 20, 2006 | BPA | $1.8K | Purchase | 900 | $1.95 | Discretionary |
| Mar 27, 2006 | BPA | $120.0K | Payment | 31,340 | $3.83 | Discretionary |
| Mar 27, 2006 | BPA | $120.0K | Option Exercise | 52,188 | $2.30 | Discretionary |